Cancer Immunotherapy Winter School Jan. 17-21, 2023 | Austin, TX & Virtual Tailored to early-to-mid career scientists and clinicians in the field of cancer immunotherapy working in academic, clinical, industry and government settings, this hybrid program provides the best in cancer...
This webinar, the ninth and final session of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind natural killer cell engagers. Basic, clinical and translational researchers in academia and industry and members of the investment community are...
01-11-2023 | 10:00 - 12:00 CT
This webinar, the eighth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind therapies involving T cell receptors. Basic, clinical and translational researchers in academia and industry and members of the investment community are the...
12-07-2022 | 14:00 - 16:00 CT
This webinar, the seventh of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind the enhanced blockade of cytotoxic T lymphocyte antigen-4 . Basic, clinical and translational researchers in academia and industry and members of the...
10-05-2022 | 13:00 - 15:00 CT
This webinar, the sixth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind induced pluripotent stem cell-derived cell therapies. Basic, clinical and translational researchers in academia and industry and members of the investment...
09-26-2022 | 10:00 - 12:00 CT
This webinar, the fourth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind the targeted systemic delivery of innate immune activators. Basic, clinical and translational researchers in academia and industry and members of the investment...
08-26-2022 | 10:00 - 12:00 CT
This webinar, the third of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind tumor-infiltrating lymphocyte therapies. Basic, clinical and translational researchers in academia and industry and members of the investment community are the...
07-28-2022 | 12:00 - 14:00 CT
This webinar, the second of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind recombinant IL-18 immunotherapy. Basic, clinical and translational researchers in academia and industry and members of the investment community are the target...
07-18-2022 | 12:00 - 14:00 CT
The Society for Immunotherapy of Cancer (SITC) hosted the 2022 SITC Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program, virtually on Jan. 24–28, 2022 . Available here are the presentation slides and video from Friday, January 28, 2022. Program...
8 attachments
The Society for Immunotherapy of Cancer (SITC) hosted the 2022 SITC Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program, virtually on Jan. 24–28, 2022 . Available here are the presentation slides and video from Thursday, January 27, 2022. Program...
15 attachments
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us